The role of caveolin1 and sprouty1 in genistein's regulation of vascular smooth muscle cell and endothelial cell proliferation

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 153-161

  Xiang, QiuLing ^a   Lin, GuiPing ^a   Xu, JinWen ^a   Zheng, ShuHui ^a   Chen, SiJuan ^a   Zhou, KeWen ^a   Wang, TingHuai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Caveolin1; Endothelial cell; Genistein; Sprouty1; Vascular smooth muscle cell

Indexed keywords

CAVEOLIN 1; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; SPROUTY 1 PROTEIN; SPROUTY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CAVEOLIN 1; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENISTEIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PHYTOESTROGENS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77957750948     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.043     Document Type: Article

References (31)

1. Antoine M., Wirz W., Tag C.G., Mavituna M., Emans N., Korff T., Stoldt V., Gressner A.M., Kiefer P. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 2005, 23:87-95.
2. Benson S.C., Iguchi R., Ho C.I., Yamamoto K., Kurtz T.W. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?. J. Hypertens. 2008, 26:973-980.
3. Bryant H.U., Dere W.H. Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc. Soc. Exp. Biol. Med. 1998, 217:45-52.
4. Carriere A., Ray H., Blenis J., Roux P.P. The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 2008, 13:4258-4275.
5. Colacurci N., Chiàntera A., Fornaro F., de Novellis V., Manzella D., Arciello A., Chiàntera V., Improta L., Paolisso G. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 2005, 12:299-307.
6. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D., McGoogan E., Menon U., Terry G., Edwards R., Brooks C., Desai M., Gie C., Ho L., Jacobs I., Pickles C., Sasieni P. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003, 362:1871-1876.
7. De Alvaro C., Martinez N., Rojas J.M., Lorenzo M. Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2. Mol. Biol. Cell 2005, 16:4454-4461.
8. Dikic I., Giordano S. Negative receptor signalling. Curr. Opin. Cell Biol. 2003, 15:128-135.
9. Dubey R.K., Jackson E.K., Gillespie D.G., Zacharia L.C., Imthum B., Keller P.J. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler. Thromb. Vasc. Biol. 2000, 20:964-972.
10. Gaus K., Le Lay S., Balasubramanian N., Schwartz M.A. Integrin-mediated adhesion regulates membrane order. J. Cell Biol. 2006, 174:725-734.
11. Hacohen N., Kramer S., Sutherland D., Hiromi Y., Krasnow M.A. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998, 92:253-263.
12. Higashi Y., Noma K., Yoshizumi M., Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J. 2009, 73:411-418.
13. Impagnatiello M.A., Weitzer S., Gannon G., Compagni A., Cotton M., Christofori G. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 2001, 152:1087-1098.
14. Lee S.H., Schloss D.J., Jarvis L., Krasnow M.A., Swain J.L. Inhibition of angiogenesis by a mouse sprouty protein. J. Biol. Chem. 2001, 276:4128-4133.
15. Little P.J., Ivey M.E., Osman N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr. Vasc. Pharmacol. 2008, 6:195-203.
16. Liu J., Razani B., Tang S., Terman B.I., Ware J.A., Lisanti M.P. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem. 1999, 274:15781-15785.
17. Mason J.M., Morrison D.J., Basson M.A., Licht J.D. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 2006, 16:45-54.
18. Nilsson J., Sjolund M., Palmberg L., Thyberg J., Heldin C.H. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA 1985, 82:4418-4422.
19. Nonami A., Taketomi T., Kimura A., Saeki K., Takaki H., Sanada T., Taniguchi K., Harada M., Kato R., Yoshimura A. The Sprouty-related protein, Spred-1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin-1. Genes Cells 2005, 10:887-895.
20. Peterson T.E., Guicciardi M.E., Gulati R., Kleppe L.S., Mueske C.S., Mookadam M., Sowa G., Gores G.J., Sessa W.C., Simari R.D. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1521-1527.
21. Razandi M., Oh P., Pedram A., Schnitzer J., Levin E.R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 2002, 16:100-115.
22. Sasaki A., Taketomi T., Wakioka T., Kato R., Yoshimura A. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor - but not epidermal growth factor-induced ERK activation. J. Biol. Chem. 2001, 276:36804-36808.
23. Somjen D., Kohen F., Jaffe A., Amir-Zaltsman Y., Knoll E., Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 1998, 32(1):39-45.
24. Somjen D., Knoll E., Kohen F., Stern N. Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells. Am. J. Hypertens. 2001, 14(12):1256-1262.
25. Sosić-Jurjević B., Filipović B., Ajdzanović V., Brkić D., Ristić N., Stojanoski M.M., Nestorović N., Trifunović S., Sekulić M. Subcutaneously administrated genistein and daidzein decrease serum cholesterol and increase triglyceride levels in male middle-aged rats. Exp. Biol. Med. (Maywood) 2007, 232:1222-1227.
26. Victor V.M., Rocha M. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases. Curr. Pharm. Des. 2007, 13:845-863.
27. Wang T.H., Fu X.D., Yang D., Tan Z., Pan J.Y. Membrane estrogen receptor mediates the rapid nongenomic activation of endothelial nitric oxide synthase by estrogen. Sheng Li Xue Bao 2003, 55:213-218.
28. 3 cascade. Eur. J. Pharmacol. 2007, 561:7-13.
29. Wang J., Zhang R., Xu Y., Zhou H., Wang B., Li S. Genistein inhibits the development of atherosclerosis via inhibiting NF-kappaB and VCAM-1 expression in LDLR knockout mice. Can. J. Physiol. Pharmacol. 2008, 86:777-784.
30. Yigzaw Y., Cartin L., Pierre S., Scholich K., Patel T.B. The C terminus of sprouty is important for modulation of cellular migration and proliferation. J. Biol. Chem. 2001, 276:22742-22747.
31. Zhang C., Chaturvedi D., Jaggar L., Magnuson D., Lee J.M., Patel T.B. Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler. Thromb. Vasc. Biol. 2005, 25:533-538.